Loading ...

CD40L antagonism in RA

(

CONTROL-RA

)

ITN Protocol #:

ITN092AI

Branded Name:

CONTROL-RA

ClinicalTrials.Gov ID:

NCT05306353

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

On Hold

Summary:

Combining a CD40L-Binding Protein (VIB4920) with a TNF-α Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis

Clinical Operations Manager

ITN Biologist

Study Personnel:

Protocol Chair

Emerson Sosaesosa@immunetolerance.org

Work: 

415-218-7981

Protocol Chair

Laura Cooney, PhDlcooney@immunetolerance.org

Work: 

734-274-1149